3-134360177-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016201.4(AMOTL2):c.1812G>C(p.Gln604His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000437 in 1,613,934 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016201.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMOTL2 | NM_016201.4 | c.1812G>C | p.Gln604His | missense_variant | Exon 7 of 10 | ENST00000249883.10 | NP_057285.3 | |
AMOTL2 | NM_001278683.1 | c.1986G>C | p.Gln662His | missense_variant | Exon 7 of 10 | NP_001265612.1 | ||
AMOTL2 | NM_001363943.2 | c.1812G>C | p.Gln604His | missense_variant | Exon 7 of 10 | NP_001350872.1 | ||
AMOTL2 | NM_001278685.2 | c.1806G>C | p.Gln602His | missense_variant | Exon 7 of 10 | NP_001265614.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152214Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000248 AC: 62AN: 249588Hom.: 0 AF XY: 0.000281 AC XY: 38AN XY: 135062
GnomAD4 exome AF: 0.000462 AC: 676AN: 1461720Hom.: 0 Cov.: 32 AF XY: 0.000436 AC XY: 317AN XY: 727148
GnomAD4 genome AF: 0.000197 AC: 30AN: 152214Hom.: 0 Cov.: 33 AF XY: 0.000202 AC XY: 15AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1812G>C (p.Q604H) alteration is located in exon 7 (coding exon 6) of the AMOTL2 gene. This alteration results from a G to C substitution at nucleotide position 1812, causing the glutamine (Q) at amino acid position 604 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at